Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

clinical trial

Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00398112

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2008-11-01
P1050medical conditionleukemiaQ29496
lymphomaQ208414
P2899minimum age18
P1132number of participants18
P6153research siteNorth Central Cancer Treatment GroupQ7054727
P580start time2007-08-01
P8363study typeinterventional studyQ78089383
P1476titleA Phase II Study of Sunitinib Malate for Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Search more.